Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis
about
Favorable results from the use of herbal and plant products in inflammatory bowel disease: evidence from experimental animal studiesBotanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A ReviewBoswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical dataFrankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity.Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells.Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical studyComplementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine?Effect of Boswellia papyrifera on cognitive impairment in multiple sclerosis.Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approachA double blind, randomized, placebo controlled clinical study evaluates the early efficacy of aflapin in subjects with osteoarthritis of knee.The in vitro antifungal activity of sudanese medicinal plants against Madurella mycetomatis, the eumycetoma major causative agent.Boswellia serrata Preserves Intestinal Epithelial Barrier from Oxidative and Inflammatory DamageBoswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkersA double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.A review of complementary and alternative approaches to immunomodulation.Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1.Integrative medicine in gastrointestinal disease: evaluating the evidence.Anti-aggregatory effect of boswellic acid in high-fat fed rats: involvement of redox and inflammatory cascades.Boswellic acids: a group of medicinally important compounds.Investigation of mitigating effect of colon-specific prodrugs of boswellic acid on 2,4,6-trinitrobenzene sulfonic acid-induced colitis in Wistar rats: Design, kinetics and biological evaluation.Phytochemicals and their potential usefulness in inflammatory bowel disease.Traditional Persian topical medications for gastrointestinal diseases.Therapeutic potential of boswellic acids: a patent review (1990-2015).A novel mTOR inhibitor is efficacious in a murine model of colitis.Blood flow patterns spatially associated with platelet aggregates in murine colitisA randomized, double blind, placebo controlled, cross over study to evaluate the analgesic activity of Boswellia serrata in healthy volunteers using mechanical pain model.Methods of inducing inflammatory bowel disease in mice.Enoxaparin improves the course of dextran sodium sulfate-induced colitis in syndecan-1-deficient mice.Role of 3-Acetyl-11-Keto-Beta-Boswellic Acid in Counteracting LPS-Induced Neuroinflammation via Modulation of miRNA-155.Prevention of colonic fibrosis by Boswellia and Scutellaria extracts in rats with colitis induced by 2,4,5-trinitrobenzene sulphonic acid.PECAM-1 (CD 31) mediates transendothelial leukocyte migration in experimental colitis.Single-Molecule Detection in Nanogap-Embedded Plasmonic Gratings.Plant terpenes: defense responses, phylogenetic analysis, regulation and clinical applications.Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohnʼs diseaseLactobacillus reuteri prevents colitis by reducing P-selectin-associated leukocyte- and platelet-endothelial cell interactions
P2860
Q26745772-85052303-822B-4915-8CFA-D0B5A9B6A532Q26998841-09708FD3-63E4-44EC-ADC4-925DC3FB4BB8Q28237079-E8963F23-4494-40BB-B4DE-9A3D80965783Q33419487-C8D6A7B7-7660-4AD6-B461-A95FE7B92645Q34101905-F4F306DF-8E20-4F59-B46C-1648AC53DD84Q34280379-7BF7D3A1-499A-4928-9765-F5D0F25DA3B7Q34419462-7EDADCA9-E068-47D1-B423-EC1494E71612Q34558974-7F7E11EA-1614-4E5A-82E5-370FFAED3BA0Q35206870-945A66A5-54D5-47BE-ACA9-8B1EF19B501EQ35407746-3662D26B-50AB-42D8-9512-674FACBCF90EQ35576645-BA3680AB-65CC-4D30-B3C3-D20C896845BBQ35625263-9DB47620-EA77-431F-9EE8-C986F559B6BBQ35635552-4CBBB018-2CA4-4E71-8035-B4E321C29322Q36955387-1D62943B-A6C5-44E9-9FDA-55253AA33751Q37060108-C329FCFA-AA20-4616-A2C1-0B7C2BFBE2D5Q37179677-C8C7AE25-897B-40FD-A005-1A9EF405F9FBQ37345889-7332C2A0-0AD5-46F7-AF71-2285BAE675E4Q37412658-A7137CD3-2950-4952-B138-7E92950D094DQ37448772-6488DF21-CCB4-486D-80F7-CBC8B5B8BA3CQ37662616-A011060A-02A3-4106-9BF4-052671B29999Q38312093-9807BB43-1C46-4A90-943E-2AF207A144F1Q38845246-A1E8E0EB-3D17-4DDF-947D-024802483A63Q38959022-EF5C1E67-5135-4BC8-B3D7-DE1B2F5D1E4CQ39928484-FF9F0D3F-8882-4D7D-8516-8CA464334D31Q40462136-C647A331-6207-4A8C-8F8D-A18B8853D197Q42087953-9413258B-67C2-4BDC-A01A-34311E36CCEFQ42721748-E2CE2B71-2A84-4619-BFE3-80122C5E2FC2Q42947929-7C541643-E9B3-401D-88C7-158601CCA263Q46159726-5C07E17A-AE97-43D9-9E4C-6241D765237DQ46588301-267C99CA-5C66-42A7-8793-E9F1E22865ADQ48597124-CB880D16-80FD-4AED-940D-C7FE9DC96A23Q55277993-1F5F75C9-FF1A-43B2-B06D-1ADE2189166CQ55347286-1C84971F-BF2A-46CE-BEBD-D97284854AD1Q56638525-28F53794-F676-4A62-962B-1DD5D5605E71Q58811536-0CC2C71D-43E1-49F4-A83C-20B263971BA5
P2860
Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Mechanisms underlying the anti ...... atives in experimental colitis
@ast
Mechanisms underlying the anti ...... atives in experimental colitis
@en
Mechanisms underlying the anti ...... atives in experimental colitis
@nl
type
label
Mechanisms underlying the anti ...... atives in experimental colitis
@ast
Mechanisms underlying the anti ...... atives in experimental colitis
@en
Mechanisms underlying the anti ...... atives in experimental colitis
@nl
prefLabel
Mechanisms underlying the anti ...... atives in experimental colitis
@ast
Mechanisms underlying the anti ...... atives in experimental colitis
@en
Mechanisms underlying the anti ...... atives in experimental colitis
@nl
P2093
P2860
P3181
P356
P1476
Mechanisms underlying the anti ...... atives in experimental colitis
@en
P2093
C F Krieglstein
D N Granger
J Bergmann
M G Laukoetter
N Senninger
R Mennigen
P2860
P304
P3181
P356
10.1152/AJPGI.00562.2005
P407
P577
2006-06-01T00:00:00Z